The Supplementary Label for Allergy Vaccines is helpful, just like the Package Insert for Medications.

In the realm of allergic and immune-mediated diseases, the topic The Supplementary Label for Allergy Vaccines It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "The Supplementary Label for Allergy Vaccines is just as helpful as the Package Insert for Medications.", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Allergological Evaluation and Informed Clinical Response
SUPPLEMENTARY LABEL FOR ALLERGY VACCINE SPECIFIC DESENSITIZING IMMUNOTHERAPY With the constant intention of better serving our patients, we inform you below of the precautions that should be taken with the desensitizing immunotherapy diluted by the physician responsible for Alergorio Prevention and Immunization of Patients, in order to preserve quality and obtain all the advantages of proper use.
1 – VACCINE PRESENTATION Injectable form, presented in 6 ml numbered vials, by dilution index or concentration, according to the composition. 2 – ALLERGY VACCINE COMPOSITION It is a preparation consisting of different allergenic extracts to which the patient has shown sensitivity in the diagnosis made by the physician. 3 – HOW THE ALLERGY VACCINE WORKS The vaccine belongs to the therapeutic group of allergenic products, being used for the treatment of IgE-mediated allergic diseases.
The product reduces allergic symptoms caused by allergens to which the patient is sensitive. This treatment is specific because each patient has different sensitivities. Only a doctor can determine the allergens to which the patient is sensitive and prescribe their proportion in the composition of an immunotherapy vaccine. The vaccine stimulates the production of specific antibodies from the first dose, and treatment is usually necessary for at least 3 years to achieve lasting effectiveness.
4 – ALLERGY VACCINE ADMINISTRATION The injection should always be administered by a healthcare professional in a medical institution. Injections should be given in the arm above the elbow via DEEP SUBCUTANEOUS (SC) injection. Injection intervals are weekly, bi-weekly, or monthly depending on the stage of treatment. The treatment schedule should be determined by your doctor; check your prescription.
After the injections, you should remain under observation for 30 minutes; Do not apply heat to the injection site; As much as possible, avoid exposure to the agents that cause your allergy; Do not perform intense physical exertion; Avoid very hot showers and saunas in the first 48 hours after the vaccine is administered. 5 – CONTRAINDICATIONS FOR ALLERGY VACCINE The vaccine is contraindicated for patients with: Severe malignant immunological diseases; Severe psychological disorders; Severe uncontrolled asthma; The use of vasodilators (antihypertensives), even in the form of eye drops, should be evaluated by a doctor, as it may be a contraindication.
Do not take this medication if you suffer from any condition in which adrenaline cannot be administered, for example, coronary artery disease or malignant hypertension, unless properly indicated and monitored by your doctor. Do not administer during an allergic reaction or fever; do not take this medication if you are hypersensitive to any component of the excipient. In case of pregnancy and lactation, seek medical advice, and if pregnancy occurs before or during treatment, inform your doctor if you are breastfeeding.
Vaccine administration is not recommended for individuals under 1 year of age or over 65 years of age without a doctor's consent; however, it may be administered if authorized by a doctor. 6 - HOW TO TRANSPORT THE ALLERGY VACCINE Allergenic products do not require refrigeration for transport for up to four days at a temperature of 37 degrees Celsius, according to studies conducted and published on the supplementary label of the supplier of the inputs, authorized by Anvisa/MS.
However, to ensure the utmost care in maintaining the physical and chemical integrity of the therapy, upon receiving the vials, our team will provide a styrofoam box that will be hermetically sealed, thus preventing abrupt temperature variations. Please remember that the product cannot be frozen or subjected to extremely high temperatures, such as (forgetting it inside a car with high temperatures, leaving it in direct sunlight, near heat sources, etc.).
7 – ALLERGY VACCINE CHECK Open each package and check each vial received, as well as whether the contents match what is described on the vial. Medical prescriptions will include information on how to calculate the contents of one cylinder (this calculation is part of the school curriculum) so that the patient, in case of doubt, can calculate the contents and verify if it matches what is stated.
8 - STORAGE OF ALLERGY VACCINE After removing the styrofoam packaging, the vials should be stored under refrigeration (2 to 8 degrees Celsius). They should never be frozen. These temperature conditions are achieved when the vials are stored inside the styrofoam box with the lid open and on the second shelf inside the refrigerator, away from the freezer. 9 – EXPIRY DATE OF ALLERGY VACCINE The vial label will contain information on the expiry date of the dilution, the diluent, and the extracts.
The patient should only carefully observe the expiration date of the dilution. Other information is for the Brazilian health authorities. 10 – ADVERSE REACTIONS TO ALLERGY VACCINES Adverse reactions to allergy vaccines are rare. They may occur in highly sensitized patients and/or in cases of overdose. MOST COMMON REACTIONS With the injectable vaccine, redness, swelling, and pain may occur on the skin at the injection site, appearing between 6 and 24 hours after injection. These are reversible and do not indicate the need to discontinue treatment, except when medically indicated.
These occur in more than 10% of patients using this medication. RARE REACTIONS Respiratory symptoms: shortness of breath, cough, chest tightness and wheezing; Generalized skin symptoms: itching, redness, rashes and swelling; Nasal and eye symptoms: itchy and swollen eyes, sneezing, nasal congestion, runny nose and watery eyes. Occurs in between 0.01% and 0.1% of patients using this medication.
VERY RARE REACTIONS Numbness and/or swelling of the tongue, throat and/or mouth (sublingual vaccine); Feeling tired, general discomfort, headache, fever and nausea, shortness of breath, stomach discomfort and/or pain, vomiting, nausea, diarrhea; Drop in blood pressure, fainting and shock. Occurs in less than 0.1% of patients using this medication. 11 – ORIGIN OF THE ALLERGY VACCINE All products supplied are from a traditional pharmaceutical industry (FDA Allergenic) that has its entire operational structure in accordance with current health regulations and diluents registered with Anvisa/Ministry of Health. All documents relating to allergy vaccines are available if the patient requests them.
Development in Evidence-Based Medicine: Bronchial Inflammation Control and Lung Function (GINA)
According to global guidelines of Global Initiative for Asthma (GINA), a bronchial asthma It is a chronic inflammatory disease of the airways characterized by bronchial hyperreactivity and variable obstruction to expiratory airflow, objectively documented by Spirometry (pulmonary function test with bronchodilator test)The fundamental therapeutic pillar consists of the continuous control of eosinophilic/Th2 inflammation of the bronchial mucosa through... inhaled corticosteroids (alone or in combination with long-acting beta-2 agonist bronchodilators — LABA, such as formoterol or salmeterol), using proper inhalation technique or a valved spacer. The isolated and repetitive use of short-acting bronchodilators (such as salbutamol or fenoterol) without inhaled anti-inflammatory coverage is associated with a higher risk of severe exacerbations and bronchial remodeling.
If you live in the West Zone of Rio, you can ask questions about Allergy vaccine in Realengo directly with the project's medical team.
💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Pharmacological Safety, Adverse Drug Reactions and Rational Use of Corticosteroids
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.
Safe Research into Therapeutic Alternatives and Prevention
Replacing emergency self-medication with a structured preventive plan protects target organs and avoids iatrogenic effects. The allergist assesses cross-reactivity between drug classes using rigorous protocols. allergy test and directs the patient with associated respiratory or skin diseases to long-term approaches, such as allergy vaccine, eliminating dependence on systemic steroidal anti-inflammatory drugs.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to The Supplementary Label for Allergy Vaccines It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




